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Exercise can exert anti-inflammatory effects in an intensity-dependent manner; however, the mechanisms
mediating these effects are continually being established. Programme Death Receptor-1 (PD-1) is a membrane
bound receptor that maintains immune tolerance by dampening immune cell interactions, such as those mediated
by cytotoxic T-cell lymphocytes (CD8þ). The aim of this study was to characterise sub-populations of CD8þ T-cells
with regards to their expression of PD-1 before and immediately after exercise. Interleukin (IL)-6, soluble PD-1
(sPD-1) and its ligand (sPD-L1) were also quantified in plasma. Eight individuals (mean  SD: age 29  5
years; BMI 24.2  3.4 kg m2; _VO2max 44.5  6.4 ml kg1⋅min1) undertook two time and energy-matched cycling
bouts in a counterbalanced study design: one of moderate intensity (MOD) and a bout of high intensity interval
exercise (HIIE). Both MOD and HIIE increased the number, but not the proportion of circulating CD8þ PD-1þ
cells, with no differences between trials. Within the CD8þ PD-1þ pool, the expression of PD-1 increased on central
memory cells following HIIE only (fold change: MOD 1.0 vs HIIE þ1.4), as well the concentration of CD8þPD-1þ
memory cells within the circulation (cells/uL: MOD -0.4 vs HIIE þ5.8). This response composed a very small part
of the exercise-induced CD8þ lymphocytosis (Pre-Ex: 0.38% to Post-Ex: 0.69%; p > 0.05). sPD-L1 and IL-6
concentration increased in tandem following MOD and HIIE (r ¼ 0.57; P ¼ 0.021), with a reciprocal decline in
sPD-1 observed. The current data demonstrate that PD-1þ CD8þ lymphocytes were mobilised following both
MOD and HIIE. Both the number of central memory CD8þ T-cells expressing PD-1 and the expression level on
these cells were increased following HIIE only. This intensity-dependent phenotypic response, in conjunction with
increased circulatory sPD-L1 may represent an aspect of the anti-inflammatory response to exercise and warrants
further investigation.1. Introduction
Regular exercise can lower systemic inflammation in both healthy
and clinical populations (Hamer et al., 2014, 2012). The cumulative
impact of acute inflammatory responses that follow individual exercise
bouts is believed to be a major stimulus for creating this
anti-inflammatory environment, which appears more marked at higher
exercise intensities (Wang et al., 2012). The mechanisms underpinning
these effects are primarily attributed to: 1) increased release of myokines& Rehabilitation Sciences Colleg
adley).
020
vier Inc. This is an open access arfrom skeletal muscle (e.g. IL-6), 2) phenotypic shifts in cell composition
(blood monocytes and adipose tissue-resident macrophages) and 3) a
reduction in the expression of membrane-bound immune receptors that
govern immune cell activity, migration and inflammatory cytokine pro-
duction (Gleeson et al., 2011). The independent contribution of these
factors is far from clear and a myriad of other mechanisms likely
contribute. For example, programmed-death receptor-1 (PD-1) is an
immune checkpoint receptor with an established role in regulating
circulating inflammatory signals (Coles et al., 2014) but is yet to bee of Life & Environmental Sciences University of Birmingham Birmingham, B15
ticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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training.
PD-1 is a membrane-bound receptor primarily expressed on lymphoid
cells that provides a ‘brake’ or checkpoint for the immune system
(Francisco et al., 2010). PD-1 interacts specifically with its co-stimulatory
ligands, PD-Ligand 1 (PD-L1) and 2 (PD-L2), which are ubiquitously
expressed. These ligand-receptor interactions result in reduced immune
cell activity and thus provide an anti-inflammatory environment that is
critical for the maintenance of immunological homeostasis. It is now well
established that aberrant expression of PD-1 can dramatically affect im-
mune function and health (Bartosinska et al., 2018; Granados et al.,
2017; Iijima et al., 2017; Ilie et al., 2016; Li et al., 2014; Lu et al., 2017;
Novak et al., 2015). High expression of PD-1 on certain immune cells
(e.g. cytotoxic T-cells (CD8þ)) is known to severely suppress immune
function in numerous blood and tissue cancers (Ilie et al., 2016; Lu et al.,
2017; Novak et al., 2015). Conversely, reduced expression of PD-1 has
been documented on CD8þ T-cells from patients with autoimmune dis-
eases, such as type-1 diabetes (Granados et al., 2017; Iijima et al., 2017),
rheumatoid arthritis (Li et al., 2014) and Psoriasis (Bartosinska et al.,
2018), driving autoimmunity. These studies underpin the central role
that PD-1 has in regulating immunological homeostasis, and yet, alter-
ations in PD-1 expression have only recently been explored for the first
time in the context of exercise (Gustafson et al., 2017).
Gustafson et al. (2017) reported that a single session of maximal
cycling marginally increased the blood composition of PD-1þ T-cells
within CD4þ (þ3.15%) and CD8þ (þ5.53%) subsets (Gustafson et al.,
2017). It is well documented that the influx of lymphocytes into the
circulation during exercise is largely driven by CD8þ, rather than CD4þ
T-cells (Turner et al., 2016), and is dependent on the intensity of the bout
(Campbell et al., 2009). The composition of this CD8þ T-cell pool is
markedly altered to favour increased immune surveillance for
antigen-presentation at secondary lymphoid organs and inflamed tissues
(Dhabhar et al., 2012). PD-1 is primarily expressed on memory cells
(Claireaux et al., 2018) and functions to limit the inflammatory response
by increasing apoptosis of antigen-specific effector T-cells (Francisco
et al., 2010); however, how antigen-specific frequencies of CD8þ T-cells
expressing PD-1 change following exercise bouts of different intensities is
currently unknown. Further to the membrane-bound forms of PD-1 and
PD-L1, soluble (s) PD-1 and sPD-L1 are detectable within the extracel-
lular environment of blood (Chen et al., 2018; Wei et al., 2018), but have
yet to be explored in the context of exercise, despite their role in
modulating T-cell activity (Kuipers et al., 2006; Song et al., 2011).
Our collective understanding of both membrane and soluble PD-1 in
the context of exercise and immunity is currently lacking, particularly
regarding how exercise alters the specific memory phenotype of T-cells
expressing PD-1, their physiological relevance in blood (i.e. number of
cells expressing PD-1) and relationships to sPD-1 and sPD-L1. Charac-
terisation of these responses could provide important insight into the
anti-inflammatory effects that underpin exercise, with important subse-
quent implications for health and immunity. The aim of the present study
was to characterise changes in the expression of PD-1 in circulating
naïve, central memory, effector memory and terminally differentiated
CD8þ T-cells following two time and energy-matched bouts of moderate
and high intensity cycling. To better understand the link between cellular
PD-1 and plasma sPD-1/sPD-L1 in the context of inflammation, sample-
matched IL-6 measurements were made.
2. Materials and methods
2.1. Participants
Following ethical approval from the University of Worcester Research
Ethics Committee, eight healthy males (mean  SD: age 29  5 years;
BMI 24.2 3.4 kg m2; _VO2max 44.5 6.4 ml kg1⋅min1) were recruited
to take part in the study. All participants completed questionnaires2addressing health history and habitual levels of weekly physical activity
using the International Physical Activity Questionnaire (IPAQ). All par-
ticipants gave their written informed consent and the study was carried
out in accordance with the Declaration of Helsinki (2008). Participants
were non-smokers and reported that they had not taken any antioxidant
vitamin supplements or anti-inflammatory drugs for 8 weeks prior to the
laboratory visit. In addition, participants reported to be free from any
viral or bacterial infections for at least 4 weeks prior to taking part.
Participants were also required to refrain from any strenuous physical
activity, consumption of alcoholic beverages or caffeine for two days
prior to each experimental session.
2.2. Experimental sessions
Participants reported to the laboratory on three separate occasions,
all carried out under stable climatic conditions (18–20 C and humidity
between 45 – 55%). Following a 30-min period of rest, resting heart rate
(RS400, Polar Electro, Finland), height (Seca Alpha, Hamburg, Germany)
and body mass (Tanita, Tokyo, Japan) were determined on each visit. On
participants first visit, cardiorespiratory fitness ( _VO2max) was assessed
using a ramp test to exhaustion on an electromagnetically braked cycle
ergometer (Lode Excalibur Sport, Groningen, Netherlands). Workload
commenced at 100 Watts and was increased by 30 Watts every 4 min.
Heart rate and oxygen uptake was assessed continuously using a breath-
by-breath system (Cortex Biophysik Metalyzer, Germany). _VO2max was
determined if two of the following criteria were met in conjunction with
a plateau in oxygen consumption after an increase in workload: volitional
exhaustion; a respiratory exchange ratio of 1.15; heart rate within 10
beats⋅min1 of the age-predicted maximal heart rate (220 - age); a drop
in cadence below 60 revolutions per minute (Howley et al., 1995). A final
obtained value of rate of oxygen consumption relative to body mass was
accepted as _VO2max (ml.kg1min1) and used to inform the workload for
the subsequent two trials.
At least one week following the _VO2max test, participants undertook
two energy and time-matched cycling trials in a counterbalanced order: a
moderate intensity bout of continuous cycling at 60% _VO2max for 58 min
(MOD) and a bout of high intensity interval exercise (HIIE), consisting of
10 x 4-min intervals at 85% _VO2max, with 2-min rest intervals. Both trials
took place following an identical overnight fast at least one week apart.
In both studies, oxygen uptake was assessed continuously to maintain
target _VO2 and ensure equal energy expenditure betweenMOD and HIIE.
Ratings of perceived exertion (RPE) were measured every 6 min during
the trials.
2.3. Blood sampling
In both MOD and HIIE, a catheter (Appleton Woods, Birmingham, UK)
was inserted into the antecubital vein of the arm prior to exercise to
obtain a baseline sample after 30 min of rest (Pre-Ex). Additional blood
samples were taken immediately (Post-Ex), 30 min (Post-Exþ30) and 60
min (Post-Exþ60) following completion of each cycling trial. At Pre and
Postþ0 timepoints, 18 ml of blood was drawn into two separate vacu-
tainer tubes containing potassium ethylene diaminetetraacetic acid
(EDTA) (Becton, Dickson & Company, Oxford, UK) for independent isola-
tion or peripheral blood monocular cells (PBMCs) and plasma. At Post-
Exþ30 and Post-Exþ60 timepoints, 9 ml of blood was collected for
plasma isolation only. The catheter was flushed every 30 min with
isotonic saline solution (0.9% sodium chloride) to prevent blood clotting.
2.4. Plasma analyses
A cytometric bead array technique was used to quantify plasma
interleukin (IL)-6 on a BD C6 Accuri Flow Cytometer (BD Biosciences,
Berkshire). Plasma PD-L1 (BMS2212; sensitivity: 0.6 pg/ml, intraassay
CV: 2.1%, interassay CV: 3.4%) and PD-1 (BMS2214; sensitivity 1.14 pg/
Table 1
Mean changes (SD) in total lymphocytes, CD3þ and CD8þ T-cells before and after
MOD and HIIE.
Pre-
Exercise
Post-Exercise Main Effects of Time Time  Trial
Interaction
Lymphocytes (cells/uL)
MOD 1720.2
(651.1)
2761.3
(1292.3) *
F (1,7) ¼ 10.7; P ¼
0.014; η2 ¼ 0.6
F (1,7) ¼ 0.03; P ¼
NS
HIIE 1559.4
(456.9)
2523.7
(1165.7) *
CD3þ T-cells (cells/uL)
MOD 1272.8
(515.1)
2022.19
(515.1) *
F (1,7) ¼ 11.7; P ¼
0.011; η2 ¼ 0.6
F (1,7) ¼ 0.02; P ¼
NS
HIIE 1180.9
(365.9)
1877.2
(870.9) *
CD8þ T-cells (cells/uL)
MOD 419.5
(161.2)
717.8 (337.4)
*
F (1,7) ¼ 15.1; P ¼
0.006; η2 ¼ 0.7
F (1,7) ¼ 0.22; P ¼
NS
HIIE 413.0
(101.7)
688.9 (310.6)
*
Legend: *P < 0.05; NS P > 0.05.
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commercially available ELISA kits (Thermo Fisher Scientific, Lough-
borough). All concentrations were corrected for changes in plasma vol-
ume based upon established criteria (Dill and Costill, 1974).
2.5. Isolation of CD8þ T-cells
Whole blood from Pre-Ex and Post-Ex timepoints only were used to
isolate PBMCs using density gradient centrifugation. Blood was diluted
1:1 with Hanks Balance Salt Solution (HBSS), and then layered carefully
on top of Histopaque 1077 (Sigma, Dorset), before centrifuging at 400g for
40 min at 21 C. The PBMC layer was aspirated and then washed three
times with HBSS, by centrifuging steps at 300g for 10min. Approximately
3 million cells per time point were then used to enrich CD8þ T-cells by
negative selection using MACS® bead separation (Miltenyi Biotec, Surrey,
UK). PBMCs were incubated with a biotin-antibody cocktail (anti-CD4,
CD15, CD16, CD19, CD34, CD36, CD56, CD123, TCRγ/δ, and CD235a),
followed by a CD8þ T-cell microbead cocktail (anti-CD14, CD61 and anti-
biotin) for 10 min at 4 C, with intermittent washes using column wash
buffer (PBS supplemented with 0.5% bovine serum albumin and 2 mM
EDTA; pH ¼ 7.2). CD8þ cells from both time-points were eluted by
negative selection using three separate MiniMACS LD-column passes,
using an excess of de-gassed column buffer (Miltenyi Biotec, Surrey, UK).
CD8þ T-cell enrichment was confirmed by flow cytometry staining ana-
lysing the CD3þCD8þ lymphocyte population (>95% purity).
2.6. Flow cytometry
Approximately 1,000,000 viable PBMCs were used for determination
of CD8þ T-cell subsets and expression of PD-1 using four-colour flow
cytometry (Guava EasyCyte, Millipore UK Ltd, Hertfordshire, UK). Cells
were incubated with fluorescently conjugated antibodies – CD3-FITC
(clone: HIT3a), CD279-PE (clone: EH12.2H7), CD45RA-PerCP (clone:
HI100), CD27-APC (clone: M-T271) (Biolegend, Cambridge, UK) for 30
min at 4 C followed by intermittent washes with PBS for 5 min at 300g.
Compensation was adjusted daily by using single stained controls and
gates established using fluorescence minus one controls. Confirmation of
non-specific antibody binding was determined by using isotope-matched
controls.
Flow cytometry data were analysed using GuavaSoft 3.1 (Millipore UK
Ltd, Hertfordshire, UK). Briefly, lymphocytes were gated on forward
versus side scatter and CD3þ and CD8þ T-cell proportions used to
determine MACS enrichment efficacy. MACS enriched CD8þ T-cells were
identified as naïve (CD27þ CD45RAþ), central memory (CD27þ
CD45RA-), effector memory (CD27 CD45RA-), or terminally differen-
tiated effector memory cells (TEMRA: CD27 CD45RAþ) accordingly (Di
Mitri et al., 2011). Within each sub-population, mean fluorescence in-
tensity (MFI) and percentage positive cells was established for PD-1
(CD279). The percentage of PD-1þ cells were used with whole blood
cell counts to determine the circulating number of PD-1þ cells in pe-
ripheral blood for each sub-population, and adjusted for changes in
plasma volume.
2.7. Statistical analysis
The Shapiro Wilk test was used to check for normality in scale data at
all time points. Variables with a non-normal distribution were log
transformed if necessary. Changes in sub-populations of immune cells,
CD8þ cells expressing PD-1, PD-1 expression levels and plasma markers
(sPD-1, sPD-L1 and IL-6) were assessed over time (Pre, Post, Post-Exþ30
and Post-Exþ60) and between Trials (MOD, HIIE) by a 2*2 (cellular data)
or 2*4 (plasma data) repeated-measures analysis of variance (ANOVA) or
Wilcoxon Signed Rank Tests, depending on variable normality. Post hoc
analysis of any ANOVA interaction effects (Trial*Time) were performed
by a test of simple effects by pairwise comparisons, with Bonferroni
correction. Mann Whitney U tests were performed to determine3differences between MOD and HIIE at different timepoints for non-
parametric data. Effect sizes for main effects and interaction effects of
ANOVA are presented as partial eta2 (η2p), using Cohen’s definition of η2p
of 0.01, 0.06 and 0.14 for ‘small’, ‘medium’ and ‘large’ effects respec-
tively (Cohen, 1988). Pearson correlation and Spearman rank were used
to assess the relationship between parametric and non-parametric data
respectively. All values are presented as means  standard deviation or
error (indicated throughout manuscript). Data were back transformed for
ease of presentation in figures. Statistical significance was accepted at the
P < 0.05 level. Statistical analyses were performed using SPSS (PASW
Statistics, release 23.0, SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Physiological response during MOD and HIIE
The physiological responses during each exercise bout are reported in
detail elsewhere (Wadley et al., 2019). Briefly, Peak _VO2 and RPE were
significantly greater in HIIE compared to MOD (P < 0.00001), but there
were no statistically significant differences in mean _VO2 and energy
expenditure.
3.2. Changes in lymphocyte sub-populations after MOD and HIIE in blood
Changes in lymphocyte and CD8þ T-cell subset concentrations are
reported in Tables 1 and 2 respectively. Total lymphocyte concentration
increased after both trials (P ¼ 0.014). Within the lymphocyte pools,
CD3þ (P ¼ 0.011) and CD8þ (P ¼ 0.006) T-cell concentrations also
increased, with no differences between MOD and HIIE for any lympho-
cyte subset. Within the CD8þ T-cell pool, naïve (P ¼ 0.050), central
memory (P ¼ 0.036), effector memory (P ¼ 0.050) and TEMRA (P ¼
0.012) all increased following MOD, but only TEMRA increased following
HIIE (P ¼ 0.049). There were no statistically significant differences in
CD8þ T-cell concentrations between MOD and HIIE at any timepoint.
3.3. Changes in PD-1þ cell concentration, expression and composition
within the CD8þ T-cell pool after MOD and HIIE
PD-1 expression was significantly higher on central and effector
memory T-cell subsets when compared to naïve or TEMRA (P’s < 0.0001).
The circulating concentration of CD8þ PD-1þ T-cells was significantly
higher after both trials (MOD: Z ¼ 2.38, P ¼ 0.017, η2 ¼ 0.35 and HIIE:
Z ¼ 1.26, P ¼ 0.234), however there were no significant differences
between trials (Z ¼ 2.10, P ¼ 0.035, η2 ¼ 0.28). Changes in PD-1þ cell
concentration and expression within CD8þ T-cell subsets are reported in
Table 2
Mean changes (SD) in CD8þ T-cell subsets before and after MOD and HIIE.
Naïve CD8þ T-cells (cells/uL)
Pre-Ex Post-Ex Time: Pre vs. Post
MOD 84.8 (120.3) 161.7 (209.8) * Z ¼ -1.96; P ¼ 0.05, η2 ¼
0.24
HIIE 81.0 (63.1) 116.8 (82.8) Z ¼ -1.12; P ¼ NS
Trial: MOD vs
HIIE
Z ¼ -0.42; P ¼
NS
Z ¼ 0; P ¼ NS
Central Memory CD8þ T-cells (cells/uL)
Pre-Ex Post-Ex Time: Pre vs. Post
MOD 50.3 (46.2) 126.0 (142.1) * Z ¼ -2.10; P ¼ 0.036, η2 ¼
0.28
HIIE 89.9 (75.8) 159.8 (158.6) Z ¼ -1.26; P ¼ NS
Trial: MOD vs
HIIE
Z ¼ -1.05; P ¼
NS
Z ¼ -0.84; P ¼
NS
Effector Memory CD8þ T-cells (cells/uL)
Pre-Ex Post-Ex Time: Pre vs. Post
MOD 113.1 (72.5) 166.9 (59.0) * Z ¼ -1.96 P ¼ 0.05, η2 ¼
0.24
HIIE 123.6 (96.1) 168.0 (127.0) Z ¼ -1.12; P ¼ NS
Trial: MOD vs
HIIE
Z ¼ 0; P ¼ NS Z ¼ -0.63; P ¼
NS
Terminally Differentiated Effector Memory CD8þ T-cells (cells/uL)
Pre-Ex Post-Ex Time: Pre vs. Post
MOD 171.3 (65.4) 263.2 (94.1) * Z ¼ -2.52; P ¼ 0.012, η2 ¼
0.40
HIIE 118.4 (98.1) 244.3 (184.5) * Z ¼ -1.82; P ¼ 0.049, η2 ¼
0.21
Trial: MOD vs
HIIE
Z ¼ -1.26; P ¼
NS
Z ¼ -0.84; P ¼
NS
Legend: *P < 0.05; NS P > 0.05.
Fig. 1. Changes in the concentrations of CD8þ T-cell subsets (naïve, central
memory, effector memory and terminally differentiated effector memory
(TEMRA) cells) before (black bars) and after (white bars) MOD (panel A) and HIIE
(panel B). Values are means  standard error. * indicates significant differences
relative to Pre-Ex: *p < 0.05.þindicates a significant difference between MOD
and HIIE:þp < 0.05.
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significant increase in PD-1þ central memory cells following HIIE only
(Z ¼ 2.31, P ¼ 0.021, η2 ¼ 0.33), with cell number significantly higher
than MOD Post-Ex (Z ¼ 2.52, P ¼ 0.010. η2 ¼ 0.40). In addition, PD-1
MFI was significantly greater in central memory cells following HIIE,
indicating an increase in receptor expression (Z¼2.24, P¼ 0.025, η2¼
0.31).3.4. Changes in sPD-1, sPD-L1 and IL-6 in response to MOD and HIIE and
associations with cellular variables
Changes in plasma levels of sPD-1 and sPD-L1 are reported in Fig. 3
sPD-L1 concentration increased immediately (MOD: Z ¼ 2.38, P ¼
0.017, η2¼ 0.35 and HIIE: Z¼2.38, P¼ 0.017, η2¼ 0.35) after exercise
and was elevated Post-Exþ30 and Post-Exþ60 (MOD: Z ¼ 2.52, P ¼
0.012, η2 ¼ 0.40 and HIIE: Z ¼ 2.52, P ¼ 0.012, η2 ¼ 0.40). A decrease
in sPD-1 concentration was observed immediately after both trials (MOD:
Z ¼ 2.52, P ¼ 0.012, η2 ¼ 0.40 and HIIE: Z ¼ 2.24, P ¼ 0.025, η2 ¼
0.31), and remained below Pre-Ex levels at Post-Exþ60 (MOD: Z ¼
2.38, P ¼ 0.017, η2 ¼ 0.35 and HIIE: Z ¼ 2.10, P ¼ 0.036, η2 ¼ 0.28).
IL-6 concentration increased above Pre-Ex at all post-exercise timepoints
in both trials (Time effect: F (3) ¼ 15.5, P < 0.0001, η2 ¼ 0.66), with the
magnitude of increase significantly greater following HIIE (Time x Con-
dition effect: F (3) ¼ 7.0, P < 0.001, η2 ¼ 0.47). A positive correlation
was noted between concentrations of IL-6 and PD-L1 Post-Ex (r ¼ 0.57; P
¼ 0.021). No statistically significant correlations were noted between
plasma and cellular variables.
4. Discussion
The current study highlights that single bouts of moderate and high
intensity interval exercise evoke an increase in the circulating concen-
tration of PD-1þ CD8þ T-cells in young, untrained, healthy males. As part4of this response, the number of PD-1þ CD8þ central memory T-cells
increased following HIIE only, with PD-1 expression also increased on
these cells. Plasma sPD-L1 and sPD-1 increased and decreased respec-
tively after both trials, with a positive association noted between IL-6 and
PD-L1. Taken together, these results highlight a phenotypic specific
change in the regulation of PD-1 on CD8þ T-cells that is exercise
intensity-dependent. Furthermore, we highlight for the first time that
soluble forms of the PD-1 receptor and ligand are reciprocally regulated
after exercise, and relate to changes in IL-6. This study provides evidence
of a potentially novel aspect of the anti-inflammatory response to exer-
cise and warrants further investigation to contextualise the findings
amongst other established mechanisms.
A single session of exercise induces large haemodynamic and β2-
adrenergic receptor-mediated changes that drive the mobilisation of
lymphocytes into the bloodstream (Graff et al., 2018). This response is
not uniform, with lymphocytes such as CD8þ T-cells with high antigen
specificity, activation and migratory capacity being preferentially
mobilised (e.g. effector T-cells) (Campbell et al., 2009). The general
consensus is that this response is highly functional, and operates to
enhance immunosurveillance and tissue remodelling in the period after
exercise (Campbell and Turner, 2018). As a result, exercise immunology
research has largely focussed on characterising CD8þ T-cells with regards
to their activation, migration and effector functions (e.g. cytotoxicity).
Conversely, relatively little attention has been paid to negative regulators
of T-cell function, which might act to suppress or modulate this
Fig. 2. Changes in the expression of PD-1 in CD8þ T-cells and their subsets
before (black bars) and after (white bars) MOD (panel A) and HIIE (panel B).
Values are means  standard error. * indicates a significant difference relative to
Pre-Ex: *p < 0.05. # indicates significantly higher expression levels in memory
T-cells subsets, compared to naïve and TEMRA: ###p < 0.0001.
Fig. 3. Changes in the concentrations of PD-L1 (A) and PD-1 (B) before (Pre-Ex)
and after (Post-Ex, Post-Exþ30 and Post-Exþ60) MOD (grey bars) and HIIE
(white bars). Values are means  standard error. * indicates a significant dif-
ference relative to Pre-Ex: *p < 0.05. # indicates a significant difference relative
to Post-Ex: #p < 0.05.
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demonstrate that both MOD and HIIE evoke an increase in PD-1þ CD8þ
T-cell concentration into the bloodstream. The magnitude of this
response was comparable between trials; however, the phenotypic re-
sponses differed, with the concentration of central memory CD8þ T-cells
expressing PD-1 (Fig. 1) and the surface expression level (MFI) on these
cells increasing after HIIE only (Fig. 2). Coupled to the finding that CD8þ
PD-1- central memory T-cells were not significantly elevated after HIIE
(data not shown), this indicates a specific phenotypic change with regards
to PD-1 regulation within the central memory T-cell pool, rather than just
changes in T-cell trafficking into the periphery.
PD-1 is a critical regulator of T-cell tolerance, modulating changes in
cell activation (Keir et al., 2007), differentiation (Ahn et al., 2018) and
migration into tissues (Brunner-Weinzierl and Rudd, 2018). Expression
of PD-1 is primarily limited to memory T-cells (Gustafson et al., 2017)
(Fig. 2), with progressive loss of the PD-1 receptor documented on T-cells
with higher effector functions, such as TEMRA, which are typically the
most sensitive to exercise-induced mobilisation (Campbell et al., 2009).
Whereas effector memory T-cells circulate between blood and peripheral
tissues, central memory T-cells circulate between lymph and blood
(Drouillard et al., 2018), awaiting antigen presentation. We speculate
that an increase in CD8þ central memory T-cell PD-1 expression after
HIIE may be a homeostatic mechanism to limit T-cell receptor activation,
differentiation and redistribution of antigen-specific T-cells from the
lymphatic system after exercise. This change is directly related to the5intensity of exercise, given that the HIIE protocol controlled for both total
exercise duration and the energy cost of exercise, compared to MOD.
The only previous study to investigate changes in immune checkpoint
expression after exercise reported an increase in the percentage of PD-
1þ, but not CTLA-4þ CD8þ T-cells after maximal cycling exercise
(Gustafson et al., 2017). A compositional increase in PD-1þ CD8þ T-cells
was not observed in the present study, and as such, suggests that pref-
erential trafficking of PD-1þ CD8þ T-cells may only increase in response
to maximal cycling exercise. Notably however, the current study subse-
quently phenotyped CD8þ T-cells, as well as determining physiologically
relevant changes within the bloodstream in response to exercise.
Importantly, the increase in CD8þ PD-1þ central memory T-cells
composed a very small component of the total exercise-induced
lymphocytosis (Pre-Ex: 0.38% to Post-Ex: 0.69%). Our data therefore
provide novel insight into changes in PD-1 within T-cells after different
intensities of exercise, both with regards to cell phenotype and physio-
logically relevant changes within the circulation. Both are undoubtedly
important in understanding changes in T-cell function and their redis-
tribution after exercise. Future work should take this approach to
establish whether a small increase in CD8þ PD-1þ central memory T-cells
has physiological relevance in governing the immune responses to ex-
ercise. For a more complete picture, other immune checkpoints, such as
CTLA-4 should be explored in this context.
Another novel finding from the present study was that exercise
evoked an increase in the circulating plasma concentration of sPD-L1 and
decrease in sPD-1 immediately, and up to 60 min post-exercise (Fig. 3).
These responses were not dependent on the intensity of exercise, nor
associated with changes in membrane-bound PD-1 expression or circu-
lating PD-1þ cell numbers. The exact cellular origin and functional ac-
tions of these soluble immune checkpoints have yet to be fully
established. Both sPD-1 (primarily released from T-cells) and sPD-L1
(released from dendritic cells and tissues) (Gu et al., 2018) can be
Fig. 4. Pearson’s correlation between Post-Ex IL-6 and sPD-L1 concentrations
across both trials (n ¼ 16).
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cleavage of the membrane-bound form directly (Zanto et al., 2011).
There is some evidence to suggest that sPD-1 and sPD-L1 may act in an
antagonistic manner, such that sPD-1 competes and sPD-L1 engages with
membrane-bound PD-1 (Gu et al., 2018; He et al., 2005). This is sup-
ported by studies suggesting that sPD-1 enhances (Yuan et al., 2004) and
sPD-L1 inhibits (Li et al., 2016) T-cell activity. From the current study, we
can therefore speculate that an increase in sPD-L1 after exercise may
form a component of the anti-inflammatory response to exercise, acting
to engage and activate membrane-bound PD-1. This is supported by a
reduction in sPD-1 concentration and a positive association between
post-exercise sPD-L1 and IL-6 (Fig. 4), a pleiotropic cytokine with a role
in anti-inflammatory signalling (Ellingsgaard et al., 2019). It must be
noted that the cellular mechanisms mediating the removal of sPD-1 from
the circulation in this short timeframe after exercise is far from clear at
present. Further work is needed to fully understand the kinetics of soluble
immune checkpoints after exercise and their functional role is regulating
communication between immune cells and tissues.
PD-1 and other immune checkpoints have attracted significant
attention in biomedical and clinical research because of their profound
impact on regulating immune tolerance in diseases associated with im-
mune dysfunction. Immune checkpoint expression is commonly elevated
on T-cells isolated from patients with blood and tissue cancers (Ilie et al.,
2016; Lu et al., 2017; Novak et al., 2015) and conversely reduced on
T-cells from patients with various autoimmune diseases (Bartosinska
et al., 2018; Granados et al., 2017; Iijima et al., 2017; Li et al., 2014).
How an increase in PD-1 expression after acute exercise translates into
changes with regular exercise training, particularly in these populations
is currently unknown. It is conceivable that exercise-induced upregula-
tion of PD-1 expression could enhance immune tolerance in patients with
certain autoimmune diseases; however, more work is needed to investi-
gate the effects of regular exercise on immune checkpoints in a clinical
context.
5. Conclusion
The results of the current study have highlighted phenotypic and
physiological relevant changes in PD-1þ CD8þ T-cells after bouts of MOD
and HIIE. PD-1þ CD8þ T-cells are mobilised in response to both types of
exercise, however, central memory CD8þ T-cells expressing PD-1
increased after HIIE only. Despite this being a very small component of
the exercise-induced lymphocytosis, PD-1 expression also increased on
these cells, highlighting a specific phenotypic response associated with
exercise at higher intensities. We have also highlighted for the first time6that soluble immune checkpoints are altered in response to exercise, with
sPD-L1 and sPD-1 increasing and decreasing up to 60 min after exercise
respectively. Further work is needed to examine the changes in mem-
brane and soluble immune checkpoints after exercise, and their relevance
to regulating health in the context of autoimmunity.
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